Shanghai Titan Scientific (688133)

Search documents
泰坦科技(688133) - 关于使用部分暂时闲置自有资金理财的公告
2025-03-19 08:15
证券代码:688133 证券简称:泰坦科技 公告编号:2025-007 上海泰坦科技股份有限公司 关于使用部分暂时闲置自有资金理财的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 上海泰坦科技股份有限公司(以下简称"公司")于 2025 年 3 月 19 日召开公司 第四届董事会第十三次会议、第四届监事会第十二次会议,审议并通过了《关于使用 暂时闲置自有资金购买理财产品的议案》,同意公司在不影响公司及子公司正常经营 及资金安全的前提下,使用额度不超过人民币 60,000 万元的闲置自有资金进行理财, 购买安全性高、流动性好、低风险类、短期(不超过 12 个月)理财产品。自公司第 四届董事会第十三次会议审议通过之日起 12 个月内有效。在前述理财额度及期限范 围内,资金可以循环滚动使用。公司董事会授权董事长、经营管理层在相应额度和决 议的有效期内行使该项决策权及签署相关文件,具体事项由公司财务管理部门负责组 织实施。现将相关情况公告如下: 一、关于使用暂时闲置的自有资金购买理财产品的情况 (一)购买理财产品目的 在不影 ...
泰坦科技(688133) - 第四届监事会第十二次会议决议公告
2025-03-19 08:15
证券代码:688133 证券简称:泰坦科技 公告编号:2025-005 上海泰坦科技股份有限公司 第四届监事会第十二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况: 上海泰坦科技股份有限公司(以下简称"公司")第四届监事会第十二次会 议通知已于 2025 年 3 月 12 日以书面方式送达全体监事,会议于 2025 年 3 月 19 日在上海市徐汇区石龙路 89 号会议室以现场结合通讯方式召开,本次会议由监 事会主席顾梁先生召集并主持,应到监事 3 人,实到监事 3 人。本次会议的召集 和召开符合《中华人民共和国公司法》和《上海泰坦科技股份有限公司章程》等 相关规定,会议形成的决议合法、有效。 二、监事会会议审议情况: 与会监事就如下议案进行了审议,并表决通过以下事项: 1、审议通过《关于开展外汇衍生品交易业务的议案》 监事会认为:公司及子公司开展外汇衍生品交易业务能够有效规避外汇市场 的风险,防范汇率大幅波动对公司业绩造成不良影响,提高外汇资金使用效率, 锁定汇兑成本。公司开展外汇 ...
泰坦科技:拟使用不超6亿元闲置自有资金进行理财
Zheng Quan Shi Bao Wang· 2025-03-19 08:07
人民财讯3月19日电,泰坦科技(688133)3月19日晚间公告,拟在不影响公司及子公司正常经营及资金安 全的前提下,使用额度不超过6亿元的闲置自有资金进行理财,购买安全性高、流动性好、低风险类、 短期(不超过12个月)理财产品。 另外,公司及子公司拟使用自有资金开展总额不超过2000万美元(或等值其他货币)额度的外汇衍生品 交易业务。 ...
泰坦科技(688133) - 2024 Q4 - 年度业绩
2025-02-27 07:50
Financial Performance - Total operating revenue for 2024 reached RMB 2,883,833,486.70, an increase of 4.12% compared to the previous year[4] - Net profit attributable to shareholders of the parent company was RMB 12,929,813.44, a decrease of 82.18% year-on-year[4] - Net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, was RMB 5,811,158.05, down 88.69% from the previous year[4] - Basic earnings per share decreased by 87.10% to RMB 0.08[4] - Operating profit fell by 84.18% year-on-year, while total profit decreased by 90.29%[8] Asset and Capital Changes - Total assets increased by 10.40% to RMB 4,844,713,066.91 compared to the beginning of the period[4] - The company's share capital increased by 39.39% due to the completion of a stock conversion in the 2023 profit distribution[10] Market and Competitive Environment - The company's gross profit margin declined due to competitive pricing strategies, impacting net profit significantly[7] - The company faced challenges from a lack of downstream demand and intensified industry competition, affecting overall performance[6] Cost and Expense Management - Management expenses and financial costs increased significantly, contributing to the decline in profitability[8]
泰坦科技(688133) - 关于自愿披露子公司研发的电子级超纯水新产品内部测试成功的公告
2025-02-26 08:00
上海泰坦科技股份有限公司(以下简称"公司")子公司安徽天地高纯溶剂 有限公司(以下简称"子公司")研发生产的电子级超纯水于近日在子公司内部 测试中获得成功。现将相关事项公告如下: 一、 新产品的基本情况 子公司成功研发生产的电子级超纯水是基于子公司高纯溶剂的成熟生产工艺,进 行升级改造,通过预处理、反渗透技术、超纯化处理以及后级处理四大步骤。运 用多级过滤、高性能离子交换单元、超滤过滤器、紫外灯、除 TOC 装置等多种处 理方法,满足国标 GB/T11446.1-2013 中最高等级 EW-I 要求,同时也满足 SEMI 国 际标准 G4 级标准。该生产工艺确保了超纯水的纯度,满足电子行业对水质的高要 求。电子级超纯水一般用于电子行业的清洗和配料,包括但不限于应用在半导体 制造、液晶显示器生产、光伏电池制造、其他电子元件生产等领域。电子级超纯 水不仅能丰富子公司电子化学品产品线,提升公司的盈利能力, 也能为半导体行 业的创新发展和效率提升提供强有力的支持。 二、 对公司的影响 证券代码:688133 证券简称:泰坦科技 公告编号:2025-003 上海泰坦科技股份有限公司 关于自愿披露子公司研发的电子级超纯水 ...
泰坦科技等在上海成立分离技术公司
Zheng Quan Shi Bao Wang· 2025-02-13 02:26
企查查股权穿透显示,该公司由泰坦科技(688133)等共同持股。 证券时报网讯,企查查APP显示,近日,奕诺微(上海)分离技术有限公司成立,法定代表人为任兴 发,注册资本1000万元,经营范围包含:生物化工产品技术研发;实验分析仪器销售;智能仪器仪表销 售;仪器仪表销售等。 ...
泰坦科技(688133) - 2024 Q4 - 年度业绩预告
2025-01-24 08:50
Financial Performance Forecast - The company expects a net profit attributable to shareholders of the parent company for 2024 to be between RMB 9.5 million and RMB 14 million, a decrease of RMB 58.57 million to RMB 63.07 million compared to the previous year, representing a year-on-year decline of 80.71% to 86.91%[2] - The net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses is expected to be between RMB 5.2 million and RMB 7.8 million, a decrease of RMB 43.59 million to RMB 46.19 million compared to the previous year, representing a year-on-year decline of 84.82% to 89.88%[2] - In 2023, the total profit was RMB 85.19 million, and the net profit attributable to shareholders of the parent company was RMB 72.57 million[3] Market Challenges - The company faced challenges due to a lack of incremental demand from downstream customers and intensified industry competition, leading to a decline in gross profit margin[4] - Despite the challenges, the company achieved a slight increase in operating revenue during the reporting period, although it fell short of initial expectations[4] - The company implemented pricing strategies and service advantages to respond to competition, which resulted in a decrease in comprehensive gross profit margin[4] Financial Data and Risks - The financial data in the performance forecast has not been audited by a registered accountant and is based on preliminary calculations by the company's financial department[5] - Investors are advised to pay attention to investment risks as the forecast data is preliminary and subject to change upon the release of the audited annual report[6]
泰坦科技(688133) - 关于5%以上股东减持计划时间届满暨减持结果公告
2025-01-08 16:00
1 彭震拟通过大宗交易方式减持,合计减持不超过 3,288,739 股,即合计减持不超 过公司总股本的 2.0000%(按计划公告时总股本 164,436,977 股计算)。 证券代码:688133 证券简称:泰坦科技 公告编号:2025-001 上海泰坦科技股份有限公司关于 5%以上股东减持 计划时间届满暨减持结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示: 股东持股的基本情况 本次减持计划实施前,股东上海创丰昕汇创业投资管理有限公司-天津创丰 昕华创业投资合伙企业(有限合伙)(原上海创丰昕汇创业投资管理有限公司- 厦门创丰昕华创业投资合伙企业(有限合伙),以下简称"天津创丰")及其一致 行动人:上海创丰昕汇创业投资管理有限公司-宁波东楷富文创业投资合伙企业 (有限合伙)(原上海创丰昕汇创业投资管理有限公司-温州东楷富文创业投资 合伙企业(有限合伙),以下简称"宁波东楷")、上海创丰昕汇创业投资管理有 限公司-上海创丰昕舟创业投资合伙企业(有限合伙)(以下简称"上海创丰")、 上海创丰 ...
泰坦科技:关于公司实际控制人续签一致行动人协议的公告
2024-12-27 08:54
证券代码:688133 证券简称:泰坦科技 公告编号:2024-050 上海泰坦科技股份有限公司 关于公司实际控制人续签一致行动人协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 上海泰坦科技股份有限公司(以下简称"公司")于 2024 年 12 月 27 日收到公 司实际控制人谢应波先生、张庆先生、张华先生、许峰源先生、王靖宇先生、张维燕 女士关于续签《一致行动人协议》的通知。鉴于各方在 2017 年 12 月 28 日签署的 《一致行动人协议》(以下简称"原《一致行动人协议》")即将到期,为完善公司 治理,保证公司经营的连续性和稳定性,实现对公司实质且有效的控制,各方续签了 《一致行动人协议》,具体情况如下: 一、本次续签《一致行动人协议》的背景情况 2、如一方拟就有关公司经营发展的重大事项向股东大会或董事会提出议案时, 须事先与协议其他各方充分进行沟通协商,在形成统一意思表示基础上,以各方 共同名义向股东大会、董事会提出议案。 截至本公告披露日,谢应波先生担任公司董事长,持有公司 9.88%的股份;张 庆先 ...
泰坦科技:2024年三季报点评:业绩承压,静待拐点
Huachuang Securities· 2024-11-18 14:01
Investment Rating - Strong Buy (Maintained) with a target price of 31 CNY [1] Core Views - The company's performance is under pressure due to declining gross margins and weakened downstream demand, with a significant drop in net profit [1][2] - Despite short-term challenges, the scientific services industry has a bright future, driven by China's innovation-driven strategy and the potential for domestic growth in the sector [2] - The company continues to invest in R&D, focusing on product and platform technologies to enhance its core capabilities [2] Financial Performance Summary - **Revenue**: 2,126 million CNY in the first three quarters of 2024, a year-on-year increase of 3.49% [1] - **Net Profit**: 10 million CNY in the first three quarters of 2024, a year-on-year decrease of 86.49% [1] - **Q3 2024 Revenue**: 729 million CNY, a year-on-year increase of 0.48% [1] - **Q3 2024 Net Profit**: 5 million CNY, a year-on-year decrease of 78.48% [1] - **Gross Margin**: 19.57% in the first three quarters of 2024, down 3.87 pct year-on-year [2] - **R&D Expenses**: 114 million CNY in the first three quarters of 2024, with continued investment in product and platform technologies [2] Industry Outlook - The scientific services industry is crucial for China's innovation-driven strategy and industrial upgrading, offering significant growth potential despite the late start compared to developed countries [2] - The industry covers a wide range of applications, providing ample opportunities for domestic scientific service providers [2] Valuation and Forecast - **2024-2026 Net Profit Forecast**: 20 million CNY, 70 million CNY, and 133 million CNY, with year-on-year changes of -73%, 258%, and 90% respectively [2] - **PE Ratio**: 198x for 2024, 55x for 2025, and 29x for 2026 [2] - **PS Valuation**: 1.7x PS for 2025, with a target market cap of 5 billion CNY and a target price of 31 CNY [2] Financial Ratios and Metrics - **Revenue Growth**: 2.1% in 2024, 6.3% in 2025, and 12.4% in 2026 [6] - **Net Profit Growth**: -73.1% in 2024, 257.8% in 2025, and 89.7% in 2026 [6] - **Gross Margin**: 20.4% in 2024, 21.5% in 2025, and 23.1% in 2026 [6] - **Net Margin**: 0.7% in 2024, 2.4% in 2025, and 4.1% in 2026 [6] - **ROE**: 0.7% in 2024, 2.4% in 2025, and 4.4% in 2026 [6]